本页面由Tiger Trade Technology Pte. Ltd.提供服务

福泰制药

483.05
-4.3800-0.90%
成交量:82.08万
成交额:3.97亿
市值:1,225.59亿
市盈率:31.53
高:492.28
开:486.35
低:481.71
收:487.43
52周最高:519.68
52周最低:362.50
股本:2.54亿
流通股本:2.54亿
量比:0.64
换手率:0.32%
股息:- -
股息率:- -
每股收益(TTM):15.32
每股收益(LYR):15.32
净资产收益率:22.54%
总资产收益率:12.16%
市净率:6.57
市盈率(LYR):31.53

数据加载中...

2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

重要事件披露

Form 8-K - Current report